Search

Your search keyword '"Klovins, Janis"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Klovins, Janis" Remove constraint Author: "Klovins, Janis" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
33 results on '"Klovins, Janis"'

Search Results

1. Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia

3. Cell-Free Microbial DNA Analysis: Effects of Blood Plasma and Serum Quantity, Biobanking Protocols, and Isolation Kits

4. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

6. Toll-Like Receptor 1 Locus Re-examined in a Genome-Wide Association Study Update on Anti–Helicobacter pylori IgG Titers

10. Contributors

13. Genetic Characteristics of Latvian Patients with Familial Hypercholesterolemia: The First Analysis from Genome-Wide Sequencing

16. A Maturity Level Model (MLM) for the self-assessment of genomic medicine practices in healthcare systems

19. Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia

21. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia

22. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis

24. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders

25. A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts

27. The Specificity and Broad Multitarget Properties of Ligands for the Free Fatty Acid Receptors FFA3/GPR41 and FFA2/GPR43 and the Related Hydroxycarboxylic Acid Receptor HCA2/GPR109A

28. Metabolomic Fingerprints in Large Population Cohorts: Impact of Preanalytical Heterogeneity

30. Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations.

31. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.

32. Changes in the Type 2 diabetes gut mycobiome associate with metformin treatment across populations.

33. Metatranscriptome analysis of blood in healthy individuals and irritable bowel syndrome patients.

Catalog

Books, media, physical & digital resources